Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.
Avisi Technologies has raised $6.3M in total funding. The most recent round was Seed. The last funding was announced in October 2023.
Avisi Technologies's investors include National Science Foundation, Gaingels, Good Growth Capital, Ben Franklin Technology Partners of Southeastern Pennsylvania, University of Pennsylvania.
Avisi Technologies is headquartered in Redwood City, United States.
Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.
Avisi Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avisi Technologies — Funding & Investors." VCBacked, October 1, 2023, https://www.vcbacked.co/company/avisi-technologies. Accessed October 31, 2026.
VCBacked. (2023). Avisi Technologies — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/avisi-technologies
{{cite web |title=Avisi Technologies — Funding & Investors |url=https://www.vcbacked.co/company/avisi-technologies |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated